FDA Finds Asbestos In Johnson & Johnson Powder; Company Recalls 33,000 Bottles

The Logical Indian Crew

October 20th, 2019 / 5:37 PM

Johnson Baby Asbestos

Image Credits: Freepik, Wikipedia (Representational)

After health regulators found traces of asbestos in a bottle of Johnson & Johnson baby (J&J) powder sold online, the company has recalled at least 33,000 powder bottles in the US.

This is the first time, the 130-year-old U.S. healthcare company has recalled its baby powder product, and also the first time that the Food and Drug Administration (FDA) announced a finding of asbestos. 

Government officials said customers should stop using powder from the affected batch “immediately”, the BBC reported.

The U.S. based company following the report had launched a review and claimed prior tests have not found asbestos traces in the powder. The firm cited “an abundance of caution” to voluntary recall one lot of baby powder produced and shipped in the U.S. in 2018. 

The company said it was working with the Food and Drug Administration (FDA) to understand the integrity and validity of both the test and results finding asbestos. The company said it is also looking at the possibility of whether the product was tampered with later, according to a BBC report

“Years of testing, including the FDA’s own testing on prior occasions – and as recently as last month – found no asbestos,” it said.

The FDA has been testing dozens of J&J products including baby powder, opioids, medical devices and the antipsychotic Risperdal for asbestos, a known carcinogen — a substance capable of causing cancer in living tissue, amid rising concerns among the public. 

The federal agency said that there was no proof that the product was counterfeit or had been tainted during testing. 

The FDA “stands by the quality of its testing and results”, it said. The regulatory body has advised customers with products from lot #22318RB to seek a refund from the company.

Soon after the news of asbestos found in the baby powder broke, shares of J&J slumped down to 6 per cent to close at $127.70 (98.7 pounds), making it the second worst-performing stock in the Dow Jones Industrial Average. 

Currently, the health giant is facing thousands of lawsuits from people who claim its talc products caused cancer. However, the company has denied those accusations. 

Also Read: Johnson & Johnson Knew About Presence Of Cancerous Asbestos In Their Baby Powder


Written by : Debarghya Sil

Edited by : Bharat Nayak

Related Stories

Bamboo Bottle Assam

Worried Of Plastic Bottles? This Man’s Bamboo Bottles From Assam Come To Rescue

Johnson Drug Test Rajasthan Cancer

Johnson & Johnson Baby Shampoo Fails Drug Regulator’s Quality Test, Company Denies The Findings

Johnson Hip Implants

SC Disposes Case Against Johnson & Johnson For Faulty Hip Implants, Victims To Get Compensation

Johnson Johnson Cancer

Johnson & Johnson Knew About Presence Of Cancerous Asbestos In Their Baby Powder

59 minute loan

Company Behind PM Modi’s 59-Minute-Loan Scheme For MSMEs Not A Private Company: SIDBI

Praveen Ranjan Auto Driver

Delhi Woman Recalls How An Auto Driver Not Only Dropped Her Safely At Midnight, Even Refused To Take Fare

Latest on The Logical Indian


Have Issued Advisories To States, UTs To Check Mob Lynchings: Govt In Parliament


ISRO To Launch Cartosat-3, Satellites To Enhance Border Security


Normalcy In Kashmir? 765 People Arrested In Cases Related To Stone-Pelting Since Revocation Of Article 370


Bengaluru Made Anti-Cancer Device Gets ‘Breakthrough’ Tag From USFDA


2,800 Men For 200 Women: Kerala Church Opens Site To Help Widows, Middle-Aged Men Find Life Partners

Fact Check

Fact Check: Are JNU Students Only Protesting Against Hike Of Rs 300 On Hostel Fee From Rs 10?


Stories that deserve attention, delivered to your inbox!

Handpicked, newsworthy stories which deserve the attention of a rational generation.